Advertisement

Topics

DiaSorin Inc. Company Profile

07:02 EST 12th December 2018 | BioPortfolio

DiaSorin S.p.A. is now a private companyDiaSorin S.p.A. originated as a diagnostic division of Sorin Biomedica S.p.A. and is today a private company that develops and manufactures reagents for in vitro diagnostics. With a large catalog of high quality products in the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity, DiaSorin is dedicated to improving the quality of life by way of assays that allow improved diagnostic decision. DiaSorin’s objective is to strengthen its presence in the global diagnostics market by focusing and responding to the changing customers and market needs.

Location

1951 Northwestern Avenue - P.O. Box 285
Stillwater
Minnesota
55082-0285
United States of America

Contact

Phone: 1.651.439.9710
Fax: 1.651.779.7847
Email: info@diasorin.com


News Articles [17 Associated News Articles listed on BioPortfolio]

QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening

QIAGEN N.V. and DiaSorin today announced the introduction of an automated, CE-marked workflow for QIAGEN’s QuantiFERON-TB Gold Plus Blood Collection Tubes (QFT-Plus BCT) and a novel DiaSorin LIAISON...

DiaSorin, Meridian sign second agreement for Liaison platform

DiaSorin SPA and Meridian Bioscience Inc. penned an agreement under which DiaSorin’s Helicobacter pylori stool antigen test will be sold on its Liaison automated detection system under the Meridian ...

FDA clears DiaSorin Molecular's group B strep assay

The FDA has granted DiaSorin Molecular clearance to market its Simplexa GBS Direct assay for qualitative detection of group B -More- 

DiaSorin Kicks off Year-long Virtual Resource Center, Complete with Educational Webinars

Starting June 25, 2018, LabRoots will host the resource center for an entire year, with access to webinars and inside tutorials on DiaSorin products. YORBA LINDA, Calif. (PRWEB) June 20, 2018 DiaSori...

QIAGEN and DiaSorin Launch Automated Testing for Latent TB infection with QuantiFERON-TB Gold Plus Technology on Widely Used LIAISON Platforms

CE-marked workflow enables efficient, high-throughput screening for tuberculosis control efforts in Europe and other markets; introduction in United States expected in 2019 and Ch...

QIAGEN und DiaSorin führen vollautomatisierte Tests auf latente TB-Infektion mit QuantiFERON-TB Gold Plus auf großflächig eingesetzten LIAISON-Plattformen ein

Der Workflow mit CE-Kennzeichnung ermöglicht effizientes Hochdurchsatz-Screening zur Tuberkulosekontrolle in Europa und anderen Märkten; Einführung in den USA voraussichtlich 2019 und in China 202....

DiaSorin: USA, Europe, JapanSales, Market Shares and Competitive Position by Product [Report Updated: 01011970] Prices from USD $3500

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

2018 DiaSorin: Market Shares and Competitive Position by Product and CountryPerformance, Capabilities, Goals and Strategies in the Global Diagnostics Industry [Report Updated: 01011970] Prices from USD $6500

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis

This study compared the performance of three automated immunoassays, Architect (Abbott), Immulite (Siemens) and Liaison (Diasorin), for Epstein-Barr virus (EBV) serology. Ninety-one serum ...

Companies [2 Associated Companies listed on BioPortfolio]

DiaSorin Inc.

DiaSorin S.p.A. is now a private companyDiaSorin S.p.A. originated as a diagnostic division of Sorin Biomedica S.p.A. and is today a private company that develops and manufactures reagents for in vitr...

DiaSorin Incorporated

DiaSorin, formerly known as INCSTAR, SORIN Diagnostics, and Sienna Biotech along with Alimenterics make up the Medical Systems Group of American Standard Company. Now as one, we provide improved healt...

More Information about "DiaSorin Inc." on BioPortfolio

We have published hundreds of DiaSorin Inc. news stories on BioPortfolio along with dozens of DiaSorin Inc. Clinical Trials and PubMed Articles about DiaSorin Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DiaSorin Inc. Companies in our database. You can also find out about relevant DiaSorin Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record